Safety, Tolerability and Pharmacokinetics of Sugammadex Using Single High Doses (Up to 96 mg/kg) in Healthy Adult Subjects: A Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Study

By Peeters Pierre A.M.  

Clinical Drug Investigation, Vol. 30, Iss. 12, 2010-12 ,pp. : 867-874

Adis International

Access to resources Recommend Favorite

Effects of Prulifloxacin on Cardiac Repolarization in Healthy Subjects: A Randomized, Crossover, Double-Blind versus Placebo, Moxifloxacin-Controlled Study

By >   >   Dionisio Paolo  

Clinical Drug Investigation, Vol. 30, Iss. 1, 2010-01 ,pp. : 5-14

Adis International

Access to resources Recommend Favorite

Drug Interaction Studies with Dexlansoprazole Modified Release (TAK-390MR), a Proton Pump Inhibitor with a Dual Delayed-Release Formulation: Results of Four Randomized, Double-Blind, Crossover, Placebo-Controlled, Single-Centre Studies

By Vakily Majid   Lee Ronald D.   Wu Jingtao   Gunawardhana Lhanoo   Mulford Darcy  

Clinical Drug Investigation, Vol. 29, Iss. 1, 2009-01 ,pp. : 35-50

Adis International

Access to resources Recommend Favorite

Lack of Interaction between Pantoprazole and Ethanol: A Randomised, Double-Blind, Placebo-Controlled Study in Healthy Volunteers

By Heinze H.  

Clinical Drug Investigation, Vol. 21, Iss. 5, 2001-01 ,pp. : 345-351

Adis International

Access to resources Recommend Favorite

Anti-Inflammatory and Antioxidant Effects of Resveratrol in Healthy Smokers A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial

By  

Current Medicinal Chemistry, Vol. 20, Iss. 10, 2013-04 ,pp. : 1323-1331

Bentham Science Publishers

Access to resources Recommend Favorite